Finance

Lists
Why is BIOA down 2.94%?
Dive Deeper
BIOA:NASDAQ
BIOAGE Labs Inc
$ 6.61
-2.94%
(-0.20) 1D
$ 6.61
0.00% (0.00)
After hours
Closed: 10-р сарын 2, 16:00:01 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BIOA...
Open
$ 6.92
High
$ 6.92
Low
$ 6.47
Mkt. cap
303.38 сая
Avg. vol.
660.85 мян
Volume
869.63 мян
52-wk high
$ 25.96
52-wk low
$ 5.05
EPS
-$ 2.39
Shares outstanding
45.90 сая
No. of employees
61
Open
$ 6.92
High
$ 6.92
Low
$ 6.47
Mkt. cap
303.38 сая
Avg. vol.
660.85 мян
Volume
869.63 мян
52-wk high
$ 25.96
52-wk low
$ 5.05
EPS
-$ 2.39
Shares outstanding
45.90 сая
No. of employees
61
News stories
From web sources and news partners
TipRanks
TipRanks
·
37 минутын өмнө
BioAge Labs initiates Phase 2 trial for BGE-102
About BIOAGE Labs Inc
CEO-
Employees61
Founded2015
HeadquartersEmeryville, Калифорни, Америкийн Нэгдсэн Улс
SectorPharmaceutical industry
Analyst ratings
Based on 9 analysts giving stock ratings to BIOA in the past 3 months
Strong buy
Buy
7
Hold
2
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for BIOA in the last 3 months.
Highest
Current $ 6.61
$ 73.00 (+1,004.39%)
Average
$ 35.63 (+439.03%)
Lowest
$ 20.00 (+202.57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Samantha Semenkow
Citi
Buy
Maintained
$ 21.00
+217.7%
09/28/2026
Joseph Stringer
Needham
Buy
Maintained
$ 35.00
+429.5%
09/14/2026
Adam Walsh
Roth MKM
Buy
Reiterated
$ 25.00
+278.2%
09/09/2026
Michael Ulz
Morgan Stanley
Hold
Maintained
$ 20.00
+202.6%
08/07/2026
Jay Olson
Oppenheimer
Buy
Maintained
$ 50.00
+656.4%
08/06/2026
Andy Hsieh
William Blair
Hold
Reiterated
-
-
08/06/2026
Yasmeen Rahimi
Piper Sandler
Buy
Reiterated
$ 73.00
+1,004.4%
08/06/2026
Thomas Shrader
BTIG
Buy
Maintained
$ 40.00
+505.1%
08/05/2026
Roger Song
Jefferies
Buy
Maintained
$ 21.00
+217.7%
07/31/2026
Last report
2026 оны 8-р сарын 5
Fiscal period
Q2 2026
EPS / Est. (USD)
-$ 0.58 / -$ 0.62
+7.09%beat
Revenue / Est. (USD)
2.45 сая / 1.50 сая
+63.65%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
2.05 сая
3.08 сая
2.77 сая
2.45 сая
Cost of goods sold
18.51 сая
24.50 сая
20.41 сая
24.36 сая
Cost of revenue
18.51 сая
24.50 сая
20.41 сая
24.36 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.68 сая
7.00 сая
7.74 сая
7.42 сая
Operating expense
6.68 сая
7.00 сая
7.74 сая
7.42 сая
Total operating expenses
25.19 сая
31.50 сая
28.15 сая
31.78 сая
Operating income
-23.14 сая
-28.42 сая
-25.38 сая
-29.33 сая
Other non operating income
-42.00 мян
-220.00 мян
-107.00 мян
-201.00 мян
EBT including unusual items
-20.17 сая
-25.94 сая
-22.25 сая
-26.10 сая
EBT excluding unusual items
-20.17 сая
-25.94 сая
-22.25 сая
-26.10 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20.17 сая
-25.94 сая
-22.25 сая
-26.10 сая
Net profit margin
-982.03%
-842.85%
-802.78%
-1,064.75%
Earnings per share
-0.56
-0.72
-0.52
-0.58
Interest and investment income
3.16 сая
2.79 сая
3.27 сая
3.44 сая
Interest expense
-149.00 мян
-92.00 мян
-39.00 мян
-1.00 мян.
Net interest expenses
3.01 сая
2.70 сая
3.23 сая
3.44 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-23.09 сая
-28.35 сая
-25.31 сая
-29.26 сая
Gain or loss from assets sale
-
23.00 мян
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс